241 related articles for article (PubMed ID: 8094899)
1. [Asthma mortality: consequences for therapy?].
Solèr M; Perruchoud AP
Schweiz Med Wochenschr; 1993 Feb; 123(5):165-9. PubMed ID: 8094899
[TBL] [Abstract][Full Text] [Related]
2. Asthma mortality in New Zealand: a two year national study.
Sears MR; Rea HH; Beaglehole R; Gillies AJ; Holst PE; O'Donnell TV; Rothwell RP; Sutherland DC
N Z Med J; 1985 Apr; 98(777):271-5. PubMed ID: 2859567
[TBL] [Abstract][Full Text] [Related]
3. Beta-agonist therapy and asthma mortality in Japan.
Beasley R; Nishima S; Pearce N; Crane J
Lancet; 1998 May; 351(9113):1406-7. PubMed ID: 9593418
[No Abstract] [Full Text] [Related]
4. Why are deaths from asthma increasing?
Sears MR
Eur J Respir Dis Suppl; 1986; 147():175-81. PubMed ID: 2876911
[TBL] [Abstract][Full Text] [Related]
5. Asthma and the beta 2-agonist controversy: much ado about something.
Lieberman JS; Kane GC
Del Med J; 1995 Dec; 67(12):624-8. PubMed ID: 8557164
[No Abstract] [Full Text] [Related]
6. Is there a problem with inhaled long-acting beta-adrenergic agonists?
Nelson HS
J Allergy Clin Immunol; 2006 Jan; 117(1):3-16; quiz 17. PubMed ID: 16387577
[TBL] [Abstract][Full Text] [Related]
7. Present state of the controversy about regular inhaled beta-agonists in asthma.
Giuntini CG; Paggiaro PL
Eur Respir J; 1995 May; 8(5):673-8. PubMed ID: 7656934
[No Abstract] [Full Text] [Related]
8. The use of beta agonists and the risk of death and near death from asthma.
Pearce N
J Clin Epidemiol; 2009 Jun; 62(6):582-7. PubMed ID: 19422997
[No Abstract] [Full Text] [Related]
9. Trends in mortality from bronchial asthma in Switzerland, 1969-1993.
La Vecchia C; Levi F; Lucchini F
Rev Epidemiol Sante Publique; 1996 Apr; 44(2):155-61. PubMed ID: 8693172
[TBL] [Abstract][Full Text] [Related]
10. Worldwide trends in asthma mortality.
Sears MR
Bull Int Union Tuberc Lung Dis; 1991; 66(2-3):79-83. PubMed ID: 1684522
[TBL] [Abstract][Full Text] [Related]
11. Part IV: Genetic variations in beta2-adrenergic receptors: long-acting and short-acting beta2-agonists and therapeutic response.
Peters S
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S29-36. PubMed ID: 17925066
[TBL] [Abstract][Full Text] [Related]
12. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
[TBL] [Abstract][Full Text] [Related]
13. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs.
Sly RM
Ann Allergy; 1994 Nov; 73(5):439-43. PubMed ID: 7978538
[TBL] [Abstract][Full Text] [Related]
14. New developments in bronchodilator therapy.
Nelson HS
Curr Opin Pulm Med; 1996 Jan; 2(1):35-9. PubMed ID: 9363113
[TBL] [Abstract][Full Text] [Related]
15. [A new long-acting asthma spray. Preliminary wait-and-see attitude?].
Flaten O
Tidsskr Nor Laegeforen; 1993 May; 113(13):1610. PubMed ID: 8101664
[No Abstract] [Full Text] [Related]
16. [beta-adrenergic agonists and mortality and morbidity in asthma].
Wever AM; Wever-Hess J
Ned Tijdschr Geneeskd; 1992 Mar; 136(10):460-5. PubMed ID: 1347647
[No Abstract] [Full Text] [Related]
17. Epidemiologic studies of beta agonists and asthma deaths.
Pearce N; Hensley MJ
Epidemiol Rev; 1998; 20(2):173-86. PubMed ID: 9919437
[No Abstract] [Full Text] [Related]
18. Managing symptoms and exacerbations in pediatric asthma.
Verberne AA
Pediatr Pulmonol Suppl; 1997 Sep; 15():46-50. PubMed ID: 9316102
[TBL] [Abstract][Full Text] [Related]
19. Bronchodilators and acute cardiac death.
Suissa S; Hemmelgarn B; Blais L; Ernst P
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1598-602. PubMed ID: 8970341
[TBL] [Abstract][Full Text] [Related]
20. Asthma.
Cates C; FitzGerald JM
Clin Evid; 2002 Jun; (7):1325-43. PubMed ID: 12230750
[No Abstract] [Full Text] [Related]
[Next] [New Search]
